全文获取类型
收费全文 | 3430篇 |
免费 | 208篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 157篇 |
妇产科学 | 76篇 |
基础医学 | 505篇 |
口腔科学 | 74篇 |
临床医学 | 318篇 |
内科学 | 720篇 |
皮肤病学 | 191篇 |
神经病学 | 202篇 |
特种医学 | 94篇 |
外科学 | 419篇 |
综合类 | 14篇 |
预防医学 | 145篇 |
眼科学 | 77篇 |
药学 | 292篇 |
中国医学 | 8篇 |
肿瘤学 | 351篇 |
出版年
2024年 | 5篇 |
2023年 | 21篇 |
2022年 | 46篇 |
2021年 | 81篇 |
2020年 | 56篇 |
2019年 | 87篇 |
2018年 | 89篇 |
2017年 | 57篇 |
2016年 | 87篇 |
2015年 | 84篇 |
2014年 | 85篇 |
2013年 | 135篇 |
2012年 | 199篇 |
2011年 | 250篇 |
2010年 | 154篇 |
2009年 | 114篇 |
2008年 | 219篇 |
2007年 | 235篇 |
2006年 | 230篇 |
2005年 | 217篇 |
2004年 | 210篇 |
2003年 | 191篇 |
2002年 | 192篇 |
2001年 | 47篇 |
2000年 | 48篇 |
1999年 | 55篇 |
1998年 | 36篇 |
1997年 | 31篇 |
1996年 | 42篇 |
1995年 | 27篇 |
1994年 | 34篇 |
1993年 | 16篇 |
1992年 | 33篇 |
1991年 | 31篇 |
1990年 | 27篇 |
1989年 | 36篇 |
1988年 | 23篇 |
1987年 | 27篇 |
1986年 | 15篇 |
1985年 | 13篇 |
1984年 | 9篇 |
1983年 | 6篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1979年 | 7篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1975年 | 3篇 |
1972年 | 5篇 |
1970年 | 7篇 |
排序方式: 共有3660条查询结果,搜索用时 15 毫秒
81.
82.
Y Akahane T Yamanaka H Suzuki Y Sugai F Tsuda S Yotsumoto S Omi H Okamoto Y Miyakawa M Mayumi 《Gastroenterology》1990,99(4):1113-1119
Some patients with type B chronic active hepatitis have a high titer of hepatitis B virus DNA despite antibody against e antigen in the serum. Clones of hepatitis B virus were propagated from the sera of seven patients with this disease, and the precore region was sequenced. Essentially all clones (128/131 or 98%) showed a point mutation from guanine to adenine at nucleotide 83, converting codon 28 for tryptophan (TGG) to a stop codon (TAG); the second guanine-to-adenine point mutation at nucleotide 86 was identified in only 29 clones from two patients. In patients followed up since they had hepatitis B e antigen, a shift from guanine to adenine was observed at nucleotide 83 along with the seroconversion to the antibody to e antigen. The precore-region product is required for the synthesis and secretion of e antigen from hepatocytes. A point mutation from guanine to adenine at nucleotide 83 observed in the seven patients, therefore, would be responsible for disturbed secretion of e antigen. 相似文献
83.
Kazumoto Iijima Mayumi Sako Mari Saito Oba Shuichi Ito Hiroshi Hataya Ryojiro Tanaka Yoko Ohwada Koichi Kamei Kenji Ishikura Nahoko Yata Kandai Nozu Masataka Honda Hidefumi Nakamura Michio Nagata Yasuo Ohashi Koichi Nakanishi Norishige Yoshikawa 《Clinical journal of the American Society of Nephrology》2014,9(2):271-278
84.
85.
Keiko Fujisawa Tetsuyuki Yasuda Hideaki Kaneto Naoto Katakami Mayumi Tsuji Fumiyo Kubo Shugo Sasaki Kazuyuki Miyashita Toyoko Naka Ryuuichi Kasami Akio Kuroda Munehide Matsuhisa Iichiro Shimomura 《Journal of diabetes investigation.》2014,5(5):548-553
Aims/Introduction
The aim of the present study was to examine the short‐ and long‐term effect of sitagliptin on glucose tolerance after near normalization of glycemic control with insulin in poorly controlled type 2 diabetic patients.Materials and Methods
We consecutively enrolled a total of 30 type 2 diabetic patients whose glycated hemoglobin levels (National Glycohemoglobin Standardization Program) were ≥7.4%, stopped all oral antidiabetic drugs and started insulin therapy. When fasting plasma glucose levels became <140 mg/dL, we carried out the first oral glucose tolerance test (OGTT). After 1‐week sitagliptin treatment (50 mg/day), the second OGTT was carried out. Furthermore, we evaluated the long‐term efficacy of sitagliptin on glucose tolerance after near normalization of glycemic control with insulin.Results
After 1‐week sitagliptin treatment, the area under the curve of insulin was markedly increased, and the area under the curve of glucagon and glucose was markedly decreased. Duration of diabetes and insulin secretory capacity were correlated with the effect of sitagliptin. Furthermore, interestingly, near normalization of glycemic control with insulin therapy for 1–2 weeks brought out the long‐term effectiveness of sitagliptin on glucose tolerance for 24 weeks, which was not observed with other antidiabetic drugs.Conclusions
These findings suggest that near normalization of glycemic control with insulin improves the clinical response to sitagliptin in poorly controlled type 2 diabetic patients. 相似文献86.
87.
88.
Ohta Shin Tanaka Akihiko Jinno Megumi Hirai Kuniaki Miyata Yoshito Yamaguchi Munehiro Homma Tetsuya Muramoto Mayumi Watanabe Yoshio Suzuki Shintaro Yokoe Takuya Sagara Hironori 《Sleep & breathing》2020,24(2):523-532
Sleep and Breathing - Obesity increases the severity of asthma, and patients with severe asthma are often complicated with obstructive sleep apnea syndrome (OSAS), a concomitant disease of obesity.... 相似文献
89.
90.
Tokushige J Ueki T Sato K Fujikawa Y Shimizu I Akahane D Sumi M Ueno M Ichikawa N Kobayashi H 《[Rinshō ketsueki] The Japanese journal of clinical hematology》2012,53(5):535-539
A 56-year-old man was diagnosed with acute myeloid leukemia with myelodysplasia-related changes. Chromosomal analysis showed a complex karyotype. Complete remission could not be achieved even after several induction chemotherapy regimens, and the patient suffered from invasive pulmonary aspergillosis. He was transferred to our hospital and underwent reduced-intensity conditioning cord blood transplantation (RIC-CBT) in a non-remission state. The conditioning regimen involved fludarabine 125 mg/m2 combined with melphalan 140 mg/m2 and total body irradiation (4 Gy). GVHD prophylaxis was tacrolimus alone at relatively low concentrations (app. 5 ng/ml). On days 6 and 9 after CBT, he experienced a pre-engraftment immune reaction and hemophagocytic syndrome (HPS). We started steroid pulse therapy, but this failed to resolve the symptoms. We then administered low-dose etoposide (50 mg/m2). The symptoms gradually resolved after three administrations of etoposide and engraftment was achieved on day 35. Satisfactory hematological recovery was noted on day 300 after CBT and the patient has maintained complete remission to date. HPS is one of the most serious complications following CBT and often results in engraftment failure. This case suggests that repeated administration of etoposide may safely and effectively overcome this serious complication in some cases. 相似文献